|
1
|
Eddy AA and Symons JM: Nephrotic syndrome
in childhood. Lancet. 362:629–639. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McKinney PA, Feltbower RG, Brocklebank JT
and Fitzpatrick MM: Time trends and ethnic patterns of childhood
nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol. 16:1040–1044.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Koskimies O, Vilska J, Rapola J and
Hallman N: Long-term outcome of primary nephrotic syndrome. Arch
Dis Child. 57:544–548. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lombel RM, Gipson DS and Hodson EM; Kidney
Disease, : Improving Global Outcomes: Treatment of
steroid-sensitive nephrotic syndrome: New guidelines from KDIGO.
Pediatr Nephrol. 28:415–426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tarshish P, Tobin JN, Bernstein J and
Edelmann CM Jr: Prognostic significance of the early course of
minimal change nephrotic syndrome: Report of the international
study of kidney disease in children. J Am Soc Nephrol. 8:769–776.
1997.PubMed/NCBI
|
|
6
|
Goumenos DS, Katopodis KP, Passadakis P,
Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V,
Vlachojannis JG and Siamopoulos KC: Corticosteroids and ciclosporin
A in idiopathic membranous nephropathy: Higher remission rates of
nephrotic syndrome and less adverse reactions than after
traditional treatment with cytotoxic drugs. Am J Nephrol.
27:226–231. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kitano Y, Yoshikawa N, Tanaka R, Nakamura
H, Ninomiya M and Ito H: Ciclosporin treatment in children with
steroid-dependent nephrotic syndrome. Pediatr Nephrol. 4:474–477.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tanaka R, Yoshikawa N, Kitano Y, Ito H and
Nakamura H: Long-term ciclosporin treatment in children with
steroid-dependent nephrotic syndrome. Pediatr Nephrol. 7:249–252.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ni SQ, Zhao W, Wang J, Zeng S, Chen SQ,
Jacqz-Aigrain E and Zhao ZY: Population pharmacokinetics of
ciclosporin in Chinese children with aplastic anemia: Effects of
weight, renal function and stanozolol administration. Acta
Pharmacol Sin. 34:969–975. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vadcharavivad S, Praisuwan S,
Techawathanawanna N, Treyaprasert W and Avihingsanon Y: Population
pharmacokinetics of tacrolimus in Thai kidney transplant patients:
Comparison with similar data from other populations. J Clin Pharm
Ther. 41:310–328. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fruit D, Rousseau A, Amrein C, Rollé F,
Kamar N, Sebbag L, Redonnet M, Epailly E, Marquet P and Prémaud A:
Ciclosporin population pharmacokinetics and Bayesian estimation in
thoracic transplant recipients. Clin Pharmacokinet. 52:277–288.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wilhelm AJ, de Graaf P, Veldkamp AI,
Janssen JJ, Huijgens PC and Swart EL: Population pharmacokinetics
of ciclosporin in haematopoietic allogeneic stem cell
transplantation with emphasis on limited sampling strategy. Br J
Clin Pharmacol. 73:553–563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang DD, Lu JM, Li Q and Li ZP: Population
pharmacokinetics of tacrolimus in paediatric systemic lupus
erythematosus based on real-world study. J Clin Pharm Ther.
43:476–483. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Y, Wu D, Dong M, Zhu Y, Lu J, Li X,
Chen C and Li Z: Population pharmacokinetics of vancomycin and
AUC-guided dosing in Chinese neonates and young infants. Eur J Clin
Pharmacol. 74:921–930. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Anderson BJ and Holford NH:
Mechanism-based concepts of size and maturity in pharmacokinetics.
Annu Rev Pharmacol Toxicol. 48:303–332. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hahn D, Hodson EM, Willis NS and Craig JC:
Corticosteroid therapy for nephrotic syndrome in children. Cochrane
Database Syst Rev. CD0015332015.PubMed/NCBI
|
|
17
|
Kauffman RE and Kearns GL: Pharmacokinetic
studies in paediatric patients. Clinical and ethical
considerations. Clin Pharmacokinet. 23:10–29. 1992. View Article : Google Scholar : PubMed/NCBI
|
